Search

everythinglearnresearchcommunity

for

Search:↓

More precise, personalized therapies are needed for autoimmune diseases.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

TGM3 is important for skin and hair structure and may help diagnose cancer.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Enzymes called PADIs play a key role in hair growth and loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

The "color-transition sign" helps tell apart alopecia areata incognita from telogen effluvium by looking at hair color changes.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Hair loss treatment caused more hair loss in a man.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Effective treatments for severe alopecia areata are still lacking.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.